Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing

Matt Wolf

👤 Person
509 total appearances

Appearances Over Time

Podcast Appearances

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

volume um you know it's we're now also kind of in the middle of conference seasons i've been talking to a lot of sponsors just about what they're seeing what they're trying to do and everybody wants to get deals done they want to deploy capital they want to exit long in the tooth um Aber die Zeitung kann noch nicht richtig sein und wir suchen für die richtigen Ziele.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

Die Verwaltungszyklen sind länger. Die makroökonomische Unwahrheit, die politische Unwahrheit, die bleibt immer mehr. Einige Ziele, nicht alle.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

Die Verwaltungszyklen sind länger. Die makroökonomische Unwahrheit, die politische Unwahrheit, die bleibt immer mehr. Einige Ziele, nicht alle.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

Die Verwaltungszyklen sind länger. Die makroökonomische Unwahrheit, die politische Unwahrheit, die bleibt immer mehr. Einige Ziele, nicht alle.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

You know, one interesting data point, though, is in terms of IPO announcements, just the number of announcements are actually up year to date over the past couple of years, which is which is a good sign, I think, you know, at least in terms of the number of announcements, not necessarily the total number.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

You know, one interesting data point, though, is in terms of IPO announcements, just the number of announcements are actually up year to date over the past couple of years, which is which is a good sign, I think, you know, at least in terms of the number of announcements, not necessarily the total number.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

You know, one interesting data point, though, is in terms of IPO announcements, just the number of announcements are actually up year to date over the past couple of years, which is which is a good sign, I think, you know, at least in terms of the number of announcements, not necessarily the total number.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

you know, market cap trying to go public, but at least the number of companies going public is, you know, those announced IPOs is higher than it's been the past couple years, year to date, which I think is strong, right? We want strong capital markets. It's an important part of the overall economy, even in the real economy, right? Access to capital. And so there's some bright spots there too.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

you know, market cap trying to go public, but at least the number of companies going public is, you know, those announced IPOs is higher than it's been the past couple years, year to date, which I think is strong, right? We want strong capital markets. It's an important part of the overall economy, even in the real economy, right? Access to capital. And so there's some bright spots there too.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

you know, market cap trying to go public, but at least the number of companies going public is, you know, those announced IPOs is higher than it's been the past couple years, year to date, which I think is strong, right? We want strong capital markets. It's an important part of the overall economy, even in the real economy, right? Access to capital. And so there's some bright spots there too.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

It's just, you know, this policy uncertainty will create

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

It's just, you know, this policy uncertainty will create

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

It's just, you know, this policy uncertainty will create

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

Ja, absolut. Und die Faktoren, die ich weiterhin schaue, sind in Bezug auf diesen Pause, es ist wirklich zweifelhaft. Einer ist einfach die Vintage der Investitionen, die da draußen sind, richtig? Also zum Beispiel Gesundheitsberatungsunternehmen, also Anbieter, Pflegegruppen, Dinge wie das, die privat beteiligt sind.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

Ja, absolut. Und die Faktoren, die ich weiterhin schaue, sind in Bezug auf diesen Pause, es ist wirklich zweifelhaft. Einer ist einfach die Vintage der Investitionen, die da draußen sind, richtig? Also zum Beispiel Gesundheitsberatungsunternehmen, also Anbieter, Pflegegruppen, Dinge wie das, die privat beteiligt sind.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

Ja, absolut. Und die Faktoren, die ich weiterhin schaue, sind in Bezug auf diesen Pause, es ist wirklich zweifelhaft. Einer ist einfach die Vintage der Investitionen, die da draußen sind, richtig? Also zum Beispiel Gesundheitsberatungsunternehmen, also Anbieter, Pflegegruppen, Dinge wie das, die privat beteiligt sind.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

We now have, we're approaching 60% of the PE-backed ones have been held for five or more years by their primary sponsor, right? Those need to get turned over. That will push deal activity. And then we also look at dry powder and middle market buyout funds. And this is, again, more healthcare specific, but it's around $250 billion of dry powder for funds that say they invest in healthcare.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

We now have, we're approaching 60% of the PE-backed ones have been held for five or more years by their primary sponsor, right? Those need to get turned over. That will push deal activity. And then we also look at dry powder and middle market buyout funds. And this is, again, more healthcare specific, but it's around $250 billion of dry powder for funds that say they invest in healthcare.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

We now have, we're approaching 60% of the PE-backed ones have been held for five or more years by their primary sponsor, right? Those need to get turned over. That will push deal activity. And then we also look at dry powder and middle market buyout funds. And this is, again, more healthcare specific, but it's around $250 billion of dry powder for funds that say they invest in healthcare.

Becker Private Equity & Business Podcast
Navigating Healthcare PE in a Shifting Market: Insights from Matt Wolf of Elliott Davis 5-14-25

And there's, you know, overlap because some funds will invest across multiple sectors. But that's an incredible amount of dry powder. a very aging portfolio that needs to turn over. And that will continue to push to get deals done. And I think we're still working through this cycle of moving from an era where